Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

Journal of Infectious Diseases

Volumn 199, Issue 6, 2009, Pages 837-846

  Egli, Adrian ^a   Infanti, Laura ^c   Dumoulin, Alexis ^a,b   Buser, Andreas ^c   Samaridis, Jacqueline ^a   Stebler, Christine ^c   Gosert, Rainer ^a   Hirsch, Hans H ^a,b,d  

^a Institute for Medical Microbiology   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Blutspendezentrum Schweizerisches Rotes Kreuz beider Basel ^*  (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DNA POLYMORPHISM; GENE SEQUENCE; HUMAN; JC VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS INFECTION; VIRUS REPLICATION;

ADULT; BK VIRUS; BLOOD DONORS; CAPSID PROTEINS; FEMALE; HUMANS; JC VIRUS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SEX CHARACTERISTICS; SWITZERLAND; URINE; VIRUS REPLICATION; YOUNG ADULT;

EID: 65649099693     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597126     Document Type: Article

References (48)

1. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147:676-84.
2. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41:354-60.
3. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315:230-4.
4. Cinque P, Koralnik IJ, Clifford DB. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol 2003; 9(Suppl 1):88-92.
5. Rinaldo CH, Hirsch HH. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007; 5:105-15.
6. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3:611-23.
7. Egli A, Binggeli S, Bodaghi S, et al. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant 2007; 22(Suppl 8):viii72- viii82.
8. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488-96.
9. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342:1309-15.
10. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193:80-7.
11. Funk GA, Gosert, R., Comoli P, Ginevri F, Hirsch HH. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8:2368-77.
12. Gosert R, Rinaldo CH, Funk GA, et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205:841-52.
13. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13:1103-9.
14. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98:1971-8.
15. Dörries K, Johnson RT, Ter Meulen V. Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization. J Gen Virol 1979; 42:49-57.
16. Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 1987; 107:78-87.
17. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997; 11:1-17.
18. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993; 167:13-20.
19. Hirsch HH, Meylan PR, Zimmerli W, Iten A, Battegay M, Erb P. HIV- 1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus. Clin Microbiol Infect 1998; 4:577-84.
20. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354:924-33.
21. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007; 84:323-30.
22. Ling PD, Lednicky JA, Keitel WA, et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 2003; 187:1571-80.
23. Dolei A, Pietropaolo V, Gomes E, et al. Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol 2000; 81:1967-73.
24. Zhong S, Zheng HY, Suzuki M, et al. Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J Clin Microbiol 2007; 45:193-8.
25. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71:115-23.
26. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184:1494-5.
27. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7:2727-35.
28. Jin L, Gibson PE, Booth JC, Clewley JP. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J Med Virol 1993; 41:11-17.
29. Randhawa PS, Gupta G, Vats A, Shapiro R, Viscidi RP. Immunoglobulin G, A, andMresponses to BK virus in renal transplantation. Clin Vaccine Immunol 2006; 13:1057-63.
30. Hariharan S, Cohen EP, Vasudev B, et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 2005; 5:2719-24.
31. Leuenberger D, Andresen PA, Gosert R, et al.Humanpolyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clin Vaccine Immunol 2007; 14:959-68.
32. Bohl DL, Brennan DC, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Storch GA. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 2008; 43:184-9.
33. Randhawa P, Bohl D, Brennan D, et al. longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 2008; 15:1564-71.
34. Egli A, Binet I, Binggeli S, et al. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med 2008; 6:29.
35. Egli A, Dumoulin A, Köhli S, Hirsch HH. Polyomavirus BK after kidney transplantation-role of molecular and immunological markers. Trends in Transplantation 2009 (in press).
36. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432-8.
37. Provenzano M, Bracci L, Wyler S, et al. Characterization of highly frequent epitope-specific CD45RA-/CCR7-/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201- BKV-seropositive donors. J Transl Med 2006; 4:47.
38. Randhawa PS, Popescu I, Macedo C, et al. Detection of CD8- T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Hum Immunol 2006; 67:298-302.
39. Li J, Melenhorst J, Hensel N, et al. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol 2006; 87:2951-60.
40. Hamilton RS, Gravell M, Major EO. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 2000; 38:105-9.
41. Viscidi RP, Rollison DE, Viscidi E, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003; 10:278-85.
42. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003; 84:1499-1504.
43. Sundsfjord A, Flaegstad T, Flo R, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169:485-90.
44. Loeber G, Dörries K. DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 1988; 62:1730-5.
45. Randhawa P, Zygmunt D, Shapiro R, et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int 2003; 64:743-7.
46. Olsen GH, Andresen PA, Hilmarsen HT, et al. Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renaltransplant patients. J Med Virol 2006; 78:384-93.
47. Markowitz RB, Eaton BA, Kubik MF, Latorra D, McGregor JA, Dynan WS. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol 1991; 65:4515-9.
48. Dörries K, Sbiera S, Drews K, Arendt G, Eggers C, Dörries R. Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals. J Neurovirol 2003; 9(Suppl 1):81-7.